Mutations in PCSK9 were first identified in two French families with hypercholesterolemia that screened negative for mutations in both the LDLR and the apolipoprotein B (apoB) genes (Abifadel et al., 2003). Here, PCSK9 is linked to familial hypercholesterolemia.